Reversible dementia and gait disturbance after prolonged use of valproic acid

Seizure

Volumn 20, Issue 6, 2011, Pages 509-511

  Evans, Matthew D ^a   Shinar, Ron ^b   Yaari, Roy ^a,c  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^c BANNER ALZHEIMER S INSTITUTE   (United States)

Author keywords

Cortical pseudoatrophy; Reversible dementia; Valproic acid

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; FLUORODEOXYGLUCOSE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

AGED; ARTICLE; BRAIN ATROPHY; BRAIN VENTRICLE DILATATION; CASE REPORT; COGNITIVE DEFECT; CONFUSION; DEMENTIA; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GAIT DISORDER; GRAND MAL SEIZURE; HUMAN; LONG TERM CARE; MEDICAL RECORD; NORMOTENSIVE HYDROCEPHALUS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; POSTURAL HEADACHE; PRIORITY JOURNAL; URINE INCONTINENCE;

AGED; ANTICONVULSANTS; CEREBRAL VENTRICLES; DEMENTIA; FEMALE; GAIT DISORDERS, NEUROLOGIC; HEARING LOSS; HUMANS; MAGNETIC RESONANCE IMAGING; SEIZURES; URINARY INCONTINENCE; VALPROIC ACID;

EID: 79958291104     PISSN: 10591311     EISSN: 15322688     Source Type: Journal    
DOI: 10.1016/j.seizure.2011.02.009     Document Type: Article

References (28)

1. E. Perucca, A. Aldenkamp, R. Tallis, and G. Kramer Role of valproate across the ages. Treatment of epilepsy in the elderly Acta Neurol Scand Suppl 184 2006 28 37 (Pubitemid 43882146)
2. C. Armon, C. Shin, P. Miller, S. Carwile, E. Brown, and J.D. Edinger Reversible parkinsonism and cognitive impairment with chronic valproate use Neurology 47 1996 626 635 (Pubitemid 26307288)
3. C.A. Galimberti, M. Diegoli, I. Sartori, C. Uggetti, A. Brega, and A. Tartara Brain pseudoatrophy and mental regression on valproate and a mitochondrial DNA mutation Neurology 67 2006 1715 1717 (Pubitemid 44747961)
4. R. Guerrini, A. Belmonte, R. Canapicchi, C. Casalini, and E. Perucca Reversible pseudoatrophy of the brain and mental deterioration associated with valproate treatment Epilepsia 39 1998 27 32 (Pubitemid 28116838)
5. M. Hauben, and L. Reich Valproate-induced parkinsonism: use of a newer pharmacovigilance tool to investigate the reporting of an unanticipated adverse event with an "old" drug Mov Disord 20 2005 387 (Pubitemid 40613307)
6. M. Iijima Valproate-induced parkinsonism in a demented elderly patient J Clin Psychiatry 63 2002 75 (Pubitemid 34113491)
7. D. Jamora, S.H. Lim, A. Pan, L. Tan, and E.K. Tan Valproate-induced Parkinsonism in epilepsy patients Mov Disord 22 2007 130 133 (Pubitemid 46382687)
8. P. Manckoundia, A. sson-Dautriche, O. Rouaud, D. Richard, B. Tavernier-Vidal, and P. Pfitzenmeyer Dementia syndrome in an elderly subject related to valproic acid use: a case report Rev Med Interne 29 2008 827 829
9. K. Masmoudi, V. Gras-Champel, I. Bonnet, M. Pannier, H. Masson, and A. Rosa Dementia and extrapyramidal problems caused by long-term valproic acid Therapie 55 2000 629 634
10. K. Masmoudi, V. Gras-Champel, H. Masson, and M. Andrejak Parkinsonism and/or cognitive impairment with valproic acid therapy: a report of ten cases Pharmacopsychiatry 39 2006 9 12 (Pubitemid 43235443)
11. R.S. McLachlan Pseudoatrophy of the brain with valproic acid monotherapy Can J Neurol Sci 14 1987 294 296 (Pubitemid 17147208)
12. M. Onofrj, A. Thomas, and C. Paci Reversible parkinsonism induced by prolonged treatment with valproate J Neurol 245 1998 794 796 (Pubitemid 28505274)
13. O. Papazian, E. Canizales, I. Alfonso, R. Archila, M. Duchowny, and J. Aicardi Reversible dementia and apparent brain atrophy during valproate therapy Ann Neurol 38 1995 687 691
14. Y.C. Park-Matsumoto, and T. Tazawa Valproate induced parkinsonism No To Shinkei 50 1998 81 84 (Pubitemid 28136281)
15. A.J. Ristic, N. Vojvodic, S. Jankovic, A. Sindelic, and D. Sokic The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy Epilepsia 47 2006 2183 2185 (Pubitemid 44952275)
16. E. Sasso, S. Delsoldato, A. Negrotti, and D. Mancia Reversible valproate-induced extrapyramidal disorders Epilepsia 35 1994 391 393 (Pubitemid 24138827)
17. L. Schreur, C.W. Middeljans-Tijssen, G.J. Hengstman, and M.G. Olde Rikkert Cognitive impairment and parkinsonism due to use of sodium valproate Tijdschr Gerontol Geriatr 40 2009 29 33
18. R. Straussberg, S. Kivity, R. Weitz, L. Harel, and N. Gadoth Reversible cortical atrophy and cognitive decline induced by valproic acid Eur J Paediatr Neurol 2 1998 213 218 (Pubitemid 28445026)
19. G.J. Walstra Reversible dementia due to valproic acid therapy Ned Tijdschr Geneeskd 141 1997 391 393 (Pubitemid 27110232)
20. H. Yamanouchi, T. Ota, G. Imataka, E. Nakagawa, and M. Eguchi Reversible altered consciousness with brain atrophy caused by valproic acid Pediatr Neurol 28 2003 382 384 (Pubitemid 36876139)
21. C. Zadikoff, R.P. Munhoz, A.N. Asante, N. Politzer, R. Wennberg, and P. Carlen Movement disorders in patients taking anticonvulsants J Neurol Neurosurg Psychiatry 78 2007 147 151 (Pubitemid 46220211)
22. B.S. Zaret, and R.A. Cohen Reversible valproic acid-induced dementia: a case report Epilepsia 27 1986 234 240 (Pubitemid 16065365)
23. L.N. Abreu, C. Issler, and B. Lafer Valproate-induced reversible pseudoatrophy of the brain and hyperammonemic encephalopathy in a bipolar patient Aust N Z J Psychiatry 43 2009 484 485
24. Y. Qian, Y. Zheng, and E. Tiffany-Castiglioni Valproate reversibly reduces neurite outgrowth by human SY5Y neuroblastoma cells Brain Res 1302 2009 21 33
25. K. Gale Role of the substantia nigra in GABA-mediated anticonvulsant actions Adv Neurol 44 1986 343 364
26. W. Loscher Pharmacological, toxicological and neurochemical effects of delta 2(E)-valproate in animals Pharm Weekbl Sci 14 1992 139 143
27. C.W. Lam, C.H. Lau, J.C. Williams, Y.W. Chan, and L.J. Wong Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) triggered by valproate therapy Eur J Pediatr 156 1997 562 564 (Pubitemid 27289858)
28. C. Armon, E. Brown, S. Carwile, P. Miller, and C. Shin Sensorineural hearing loss: a reversible effect of valproic acid Neurology 40 1990 1896 1898